AKR1B1 / ALDR1 (1-316) Human Protein
CAT#: AR09146PU-N
Recombinant human Aldo-keto reductase 1B1/AKR1B1 protein
Need it in bulk or customized? Get a free quote |
CNY 8000.00
货期*
详询
规格
Cited in 1 publication. |
Specifications
Product Data | |
Species | Human |
Expression Host | E. coli |
Expression cDNA Clone or AA Sequence |
MASRLLLNNG AKMPILGLGT WKSPPGQVTE AVKVAIDVGY RHIDCAHVYQ NENEVGVAIQ EKLREQVVKR EELFIVSKLW CTYHEKGLVK GACQKTLSDL KLDYLDLYLI HWPTGFKPGK EFFPLDESGN VVPSDTNILD TWAAMEELVD EGLVKAIGIS NFNHLQVEMI LNKPGLKYKP AVNQIECHPY LTQEKLIQYC QSKGIVVTAY SPLGSPDRPW AKPEDPSLLE DPRIKAIAAK HNKTTAQVLI RFPMQRNLVV IPKSVTPERI AENFKVFDFE LSSQDMTTLL SYNRNWRVCA LLSCTSHKDY PFHEEF
|
Predicted MW | 35.8 kDa (316aa) confirmed by MALDI-TOF |
Concentration | 1mg/ml (determined by Bradford assay) |
Purity | > 95% by SDS-PAGE |
Buffer | Liquid in. 20mM Tris-HCl buffer (pH 8.0) containing 1mM DTT, 10% glycerol |
Preparation | Liquid purified protein |
Applications | SDS-PAGE, Enzyme Activity |
Protein Description | Recombinant Aldose reductase (AKR1B) protein was expressed in E.coli and purified by using conventional chromatography techniques. |
Storage | Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80C. Avoid repeated freezing and thawing cycles. |
Stability | Shelf life: one year from despatch. |
Bioactivity | Specific activity is >800pmol/min/ug, and is defined as the amount of enzyme that catalyze the reduction of 1.0pmole DL-glyceraldehyde in the presence of NADPH per minute at pH7.0 at 37C. |
Endotoxin | < 1 EU per 1ug of protein (determined by LAL method) |
Reference Data | |
RefSeq | NP_001619.1 |
Locus ID | 231 |
UniProt ID | P15121 |
Cytogenetics | 7q33 |
Synonyms | Aldo-keto reductase family1 member B1, AKR1B1, ADR, ALDR1, ALR2, AR, Aldose reductase, AKR1B 1, Aldehyde reductase, aldr 1, aldr-1, Lii5-2 CTCL tumor antigen, low Km aldose reductase |
Summary | This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member catalyzes the reduction of a number of aldehydes, including the aldehyde form of glucose, and is thereby implicated in the development of diabetic complications by catalyzing the reduction of glucose to sorbitol. Multiple pseudogenes have been identified for this gene. The nomenclature system used by the HUGO Gene Nomenclature Committee to define human aldo-keto reductase family members is known to differ from that used by the Mouse Genome Informatics database. [provided by RefSeq, Feb 2009] |
Protein Families | Druggable Genome |
Protein Pathways | Fructose and mannose metabolism, Galactose metabolism, Glycerolipid metabolism, Metabolic pathways, Pentose and glucuronate interconversions, Pyruvate metabolism |
Citations (1)
The use of this Proteins has been cited in the following citations: |
---|
Molecular Interactions and Implications of Aldose Reductase Inhibition by PGA1 and Clinically Used Prostaglandins
,Dmez-Dacal B, Sanchez-Gsmez FJ, Sanchez-Murcia PA, Milackova I, Zimmerman T, Ballekova J, Garcma-Martmn E, Agzndez JA, Gharbi S, Gago F, Stefek M, Pirez-Sala D,
Mol. Pharmacol.
,PubMed ID 26487510
[AKR1B1]
|
Documents
FAQs |
SDS |
Customer
Reviews
Loading...